icon-folder.gif   Conference Reports for NATAP  
 
  EASL 48th Annual Meeting
April 24th - 28th 2013
The Netherlands, Amsterdam
Back grey_arrow_rt.gif
 
 
 
Tenofovir Disoproxil Fumarate in Chronic HBV Patients With Normal ALT Levels and High HBV DNA Levels, also titled: TENOFOVIR DF (TDF) COMPARED TO EMTRICITABINE (FTC)/TDF IN HBeAg-POSITIVE, CHRONIC HEPATITIS B (CHB) VIRUS-INFECTED PATIENTS IN THE IMMUNE TOLERANT (IT) PHASE
 
 
  Reported by Jules Levin EASL 2013 Amsterdam April 24-28
 
Henry L.Y. Chan1, Chi Kuen Chan2, Aric Josun Hui3, Sing Chan4, Fred Poordad5, Ting-Tsung Chang6, Philippe Mathurin7, John F. Flaherty8, Lanjia Lin8, Amoreena Corsa8, Anuj Gaggar8, G. Mani Subramanian8, John G. McHutchison8, Sam Lee9, Edward J. Gane10
 
1Prince of Wales Hospital, Hong Kong; 2Queen Mary Hospital, University of Hong Kong; 3Alice Ho Miu Ling Nethersole Hospital, Hong Kong; 4Private Practice, Flushing, NY, USA; 5Alamo Medical Research, San Antonio, TX, USA; 6National Cheng Kung University Hospital, Tainan, Taiwan; 7H˘pital Claude Huriez, Lille, France; 8Gilead Sciences, Inc., Foster City, CA, USA; 9Heritage Medical Research Clinic, University of Calgary, Alberta, Canada; 10Auckland General Hospital, Auckland, New Zealand

EASL1.gif

EASL2.gif

EASL3.gif

EASL4.gif

EASL5.gif

EASL6.gif

EASL7.gif

EASL8.gif

EASL9.gif